A US funding shock is forcing European labs to rewrite grant agreements, data-sharing rules and hiring plans.

The European Commission's Choose Europe for Science portal opened in early May 2025 with research jobs and fellowships across 13 EU member states. The launch came four months after the US National Institutes of Health announced a flat 15 per cent cap on indirect cost payments, down from negotiated rates that usually run between 30 and 60 per cent. Federal courts quickly paused that cap, but the broader freeze had already reached European consortia through stop-work orders and grant terminations.

European rectors and research offices are going past welcoming statements. They are amending consortium agreements, moving subawards to non-US partners, setting aside bridge funding and rebuilding data-sharing annexes. The tempo differs by field: biomedical collaborations moved first, climate and social science projects followed when US agencies began reviewing awards for diversity-related language.

Why the freeze reached European consortia so quickly

US agencies route their share of a joint project through subawards, equipment purchases, travel and salary lines. When the National Institutes of Health froze new grant review panels in January 2025 and later terminated awards, European partners discovered that a single US stop-work order can halt the entire consortium's payment schedule. The indirect cost cap added a second problem. Even where direct research continued, US institutions faced a sudden shortfall on facilities and administration support of 15 to 45 percentage points against their negotiated rates. That shortfall does not stay inside American accounting. It changes what US partners can subcontract, which personnel can travel, and whether data can be transferred.

A Department of Government Efficiency review and multiple lawsuits made the timeline worse. Universities could not tell European collaborators whether an award was paused for administrative review or cancelled outright. In some consortia, coordinators began drafting amendments after waiting three weeks for a response that never came.

What universities are changing first

Legal changes lead. Universities in Germany, the Netherlands, Denmark and Sweden are rewriting consortium agreements to add pre-agreed replacement clauses. If a US partner cannot invoice or loses a federal subaward, the consortium can move that work package to another institution without renegotiating the full grant. In the Netherlands, one research office circulated a model amendment within a week of the National Institutes of Health cap. The legal mechanics are less visible than a recruitment website, but they determine whether a project can keep moving.

Financial reserves are the second adjustment. Dutch and Swedish research offices created small internal reserve funds to cover two to four months of a partner's share while the consortium finds a replacement. Data governance came later, because European data protection officers first had to ask whether US-held research data would remain accessible if a federal agency's data-sharing requirements changed under a stop-work order. That question has no uniform answer, so universities are treating data as a separate work package with its own contingency. The US-side legal machinery is covered in earlier reporting on Title VI disputes and grant compliance, which shaped how quickly some consortia moved.

Recruitment turns into retention policy

The Choose Europe for Science portal brings job advertisements and fellowship calls into one place. The Commission built it around a simple assumption: researchers affected by US policy should not have to search each national system separately. France followed with a national platform for researchers considering a move. Aix-Marseille Université launched a Safe Place for Science track with multi-year packages for researchers leaving the United States, an explicit institutional response rather than a general recruitment slogan.

The European Research Council's rules already let a grant holder move to a new host institution in an EU or associated country. The new political pressure has made that portability more visible. Research offices are using it to reassure mid-career US scientists who have an active European Research Council grant but can no longer run all of its work packages from an American university.

The base rate and the exception

The base rate is continuity. Most European labs with US co-investigators report that projects are continuing because consortium agreements already include amendment clauses and because European funders have not frozen their share. The exception is concentrated in US government-funded health and climate projects, where stop-work orders and political review of grant language made US partners unable to invoice. European universities have not seen a mass cancellation of joint projects; they have seen a mass pre-nuptial rewriting of them.

Horizon Europe remains the largest European funding instrument for cross-border research. US organisations can participate as partners, but they are not automatically funded unless the European Commission considers their participation essential. The freeze has made coordinators more cautious about naming a US partner as essential. Some proposals now name an EU-based replacement in the submission phase, a change that costs little and saves months if an award action is delayed. The current rules are published on the European Commission's Horizon Europe page.

The clearest number sits in the indirect cost gap: 15 per cent imposed against negotiated rates of 30 to 60 per cent. In a lab I know well, that gap turned a single joint award into a six-week legal problem. A collaborator — call him Dr. M — runs a sequencing core in Heidelberg. His US partner was four months into a joint genetics award when the federal agency stopped reimbursing travel and postponed a subaward. The consortium amended the grant in two weeks, shifting the subaward to a Copenhagen group that had already been working on the same cohort. The scientific question did not change. The legal and financial wrapper did.

What this means for your lab

Treat every US partner as a contingent partner until the award action is confirmed in writing. European universities are building practical habits: a model amendment clause, a named replacement partner for each US work package, a data export plan that survives a stop-work order, and one file owner who checks the clause every quarter. You do not need a policy document for this. You need the same discipline that keeps a lab running: one shared folder and one versioned agreement.

For early-career researchers, the jobs market is shifting. The portal and national schemes have made relocation from the United States cheaper and more visible, but the roles still require a host institution and a funded position. Search the research and postdoctoral listings that match your field, then contact the host group before you submit. A named contact inside the lab beats a portal application.

The recruitment drives solve the job advertisement problem. They do not solve the visa, pension, dual-career or housing problems that make a mid-career move difficult. A researcher accepting a French package still has to transfer grant funds, negotiate a start-up package, handle a spouse's work permit and manage lab equipment imports. Universities that run successful campaigns pair the portal listing with a named case manager. Those that do not are collecting CVs, not hiring people.

One step this month

Review the amendment clause in every consortium agreement that includes a US partner. If the clause requires unanimous consent of all partners, ask your research office whether it can be replaced by a pre-agreed substitution mechanism. That single change costs nothing and determines whether a US funding freeze becomes a European project failure or a two-month administrative detour. For relocation and practical guidance, EURAXESS remains the standard first stop.

Photo by SPIRIDON KOUFOS on Unsplash